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The desmoglein compensation hypothesis, namely
that one desmoglein can compensate for loss of
function of another, has been proposed to explain
the tissue speci®city of the autoantibody-induced loss
of cell adhesion in pemphigus. To validate this
hypothesis genetically, we used desmoglein-3 knock-
out mice (DSG3±/±) that lose their telogen hair pre-
maturely due to loss of adhesion between
keratinocytes of the telogen hair club and the outer
root sheath, where the only desmoglein expressed in
normal mice is desmoglein-3. To determine if des-
moglein-1 could substitute for the function of des-
moglein-3 in telogen hair, we produced transgenic
mice that express desmoglein-1 driven off the keratin
14 promoter, and then bred the transgene (TG) into
DSG3±/± mice. Immunoblotting showed transgene
expression in skin, and immuno¯uorescence showed
desmoglein-1 in the telogen club of DSG3±/±
TG+ but not DSG3±/±TG± mice. DSG3±/±TG±
mice lost telogen hair with each wave of telogen,
whereas DSG3±/±TG+ mice had markedly delayed
and decreased hair loss. DSG3±/± mice also show
low weights due to blisters in the oral mucosa.
Surprisingly, DSG3±/±TG+ mice showed similar low
weights, because the transgene, although expressed
in skin, was not well expressed in oral mucous mem-
branes. These studies show that desmoglein-1 can
compensate for loss of desmoglein-3-mediated adhe-
sion, and provide genetic evidence con®rming the
desmoglein compensation hypothesis. Key words: cad-
herin/desmosome/hair. J Invest Dermatol 119:27±31, 2002
D
esmosomes are multiprotein complexes that mediate
epithelial tissue structure and integrity. Two types of
transmembrane glycoproteins, desmogleins (Dsg)
and desmocollins, play important roles in the
formation and maintenance of desmosomes
(Kowalczyck et al, 1999; Green and Gaudry, 2000). Both
glycoproteins exist in three isoforms encoded by separate genes
that are members of the cadherin supergene family.
Evidence from antibody and genetic studies suggest that Dsg play
critical roles in the maintenance of cell adhesion by desmosomes.
The ®rst line of evidence comes from studies of pemphigus
patients. These patients, whose disease is manifest as blisters due to
loss of keratinocyte cell adhesion, have anti-Dsg autoantibodies
®xed in their epidermis and circulating in their blood (Udey and
Stanley, 1999). These anti-Dsg autoantibodies have been shown to
cause loss of cell adhesion in organ culture of normal skin, without
the addition of in¯ammatory cells or complement, suggesting that
they directly inactivate the adhesion function of Dsg (Schiltz and
Michel, 1976). Furthermore, passive transfer of these anti-Dsg
autoantibodies into neonatal mice causes blisters due to loss of
keratinocyte cell±cell adhesion (Anhalt et al, 1982; Amagai et al,
1994, 1995).
If, as suggested by the above ®ndings, anti-Dsg autoantibodies
actually inactivate Dsg to cause loss of cell adhesion, then genetic
loss of Dsg should mimic antibody-induced disease. This later
®nding has been shown with DSG3±/± mice (Koch et al, 1997).
These mice show loss of cell adhesion and blisters in the basal and
immediate suprabasal layer of mucous membrane and skin, similar
to that seen in pemphigus vulgaris patients who have anti-Dsg3
autoantibodies.
A complicating issue in trying to understand the pathophysiology
of pemphigus has been that there are two major types of disease,
called pemphigus vulgaris and pemphigus foliaceus, in which there
are distinct anti-Dsg antibody pro®les and in which blisters develop
in different, but characteristic, tissue distributions (Mahoney et al,
1999; Udey and Stanley, 1999). For example, pemphigus foliaceus
patients have anti-Dsg1 antibodies and develop blisters only in the
super®cial epidermis, but not the deep epidermis and not in
mucous membranes at all, even though the anti-Dsg1 antibodies
bind to all these regions. An explanation put forward to explain this
apparent paradox has been termed the Dsg compensation hypoth-
esis. This hypothesis states that both Dsg1 and Dsg3 maintain
adhesion in the desmosome, and, in areas where both are expressed,
one can compensate for antibody-induced loss of function of the
other. Therefore, although anti-Dsg1 antibodies may inactivate the
function of Dsg1 in deep epidermis and mucous membrane, as the
Dsg3 isoform is also expressed in those locations no spontaneous
blister forms. In normal super®cial epidermis, however, only Dsg1
is expressed so that antibody-induced inactivation causes a blister
there.
Although the correlation of blister localization, Dsg distribution,
and anti-Dsg pro®les in pemphigus is consistent with the Dsg
compensation hypothesis, we sought more direct genetic proof that
one Dsg could substitute in adhesion for another. To do so, we
used the DSG3±/± mouse. The most striking phenotype of this
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mouse is cyclical baldness from premature loss of telogen hair due
to loss of cell adhesion of keratinocytes between the telogen hair
club and the outer root sheath of the hair follicle (Koch et al, 1998).
This area of the hair follicle normally contains only Dsg3 so that in
the Dsg3±/± mouse there are no Dsgs, resulting in spontaneous loss
of keratinocyte adhesion. The result is that as soon as the hair goes
into synchronized telogen in the ®rst hair cycle, the hair, which is
normally ®rmly anchored until the next anagen hair replaces it, is
lost. Subsequent hair cycles also show loss of telogen hair. The
other phenotype of these DSG3±/± mice is poor weight gain
presumably due to blisters in the basal layer of the mucous
membranes where suckling causes trauma that, due to the loss of
the normally expressed Dsg3, in turn causes loss of cell adhesion.
We used this DSG3±/± mouse, with its easily assessed phenotypes
of loss of cell±cell adhesion, to determine whether Dsg1 could
substitute for Dsg3 in the basal layer by breeding in a Dsg1
transgene (TG) expressed off a keratin 14 promoter. The results of
these genetic studies directly validate the Dsg compensation
hypothesis.
MATERIALS AND METHODS
Construction and genotyping of K14-DSG1 transgenic mice and
DSG3 knockout mice carrying K14-DSG1 The keratin 14 promoter
vector (pG32K14), which also contains the rabbit b-globin intron and
K14 polyadenylation site, was a gift from Drs Elaine Fuchs and
Toshihiro Tanaka (Vassar et al, 1989; Saitou et al, 1995). First, the
keratin 14 promoter cassette was subcloned into pGEM-3Z (Promega,
Madison, WI) vector (pGEM-K14). Mouse cDNA encoding Dsg1 was
cloned as previously described (Amagai et al, 2000). Polymerase chain
reaction (PCR) of the 3¢ end was used to add 27 nucleotides that
encode the FLAG octapeptide epitope, and the resultant cDNA was
cloned into BamHI sites of the pGEM-K14. The ®nal sequence was
con®rmed by nucleotide sequencing. The TG containing the K14
promoter and mouse DSG1-FLAG was excised from pGEM-3Z with
HindIII and XhoI (Fig 1A), and then microinjected into the male
pronuclei of B6SJLF1/J mice zygotes prior to implantation into
pseudopregnant foster CD±1 mice.
DNA extracted from tails of mice (Puregene Genomic DNA Isolation
Kit, Gentra Systems, Minneapolis, MN) was used for PCR and Southern
blotting to establish genotypes. PCR primers from the rabbit b-globin
intron and Dsg1 were used to identify transgenic DNA (288 bp,
Fig 1B). After con®rmation with Southern blotting, two independent
TG lines were bred to the DSG3±/± line (Koch et al, 1997). Genotyping
by PCR for DSG3±/± mice was described previously (Mahoney et al,
1999). PCR for the TG and for detecting the DSG3±/± phenotype were
done simultaneously (Fig 1B).
Antibodies Rabbit antibodies against the extracellular domain of
mouse Dsg1 (Mahoney et al, 1999), the extracellular domain of mouse
Dsg3 (Koch et al, 1998), and the FLAG epitope (Abcam, U.K.) were
used for immuno¯uorescence staining. A monoclonal antibody against
the FLAG epitope (M2, Sigma, St. Louis, MO) was used for
immunoblotting.
Immunohistochemistry and immunoblotting Indirect immuno-
¯uorescence of formalin-®xed mouse skin with rabbit antibodies against
Dsg1 and Dsg3 was described previously (Wu et al, 2000). Non-®xed
cryosections of mouse skin were used for indirect immuno¯uorescence
to detect FLAG epitope staining.
For immunoblotting, mouse back skin or mucous membrane (tongue)
was homogenized on dry ice and then extracted with Laemmli sample
buffer (Bio-Rad, Hercules, CA). Samples with equal protein amounts
(Protein assay kit, Bio-Rad) were electrophoresed on 6% Tris±glycine
polyacrylamide gels (Novex, San Diego, CA) and then transferred to
nitrocellulose sheets (Trans blot, Bio-Rad). The sheets were incubated
for 1 h in blocking buffer, 5% skim milk powder in Tris-buffered saline
(50 mM Tris±HCl, pH 7.4, 150 mM NaCl). The FLAG M2 antibody
conjugated with horseradish peroxidase (Sigma), diluted in blocking
buffer, was applied for 1 h at room temperature. After two washes with
0.1% Tween-20 in Tris-buffered saline, the signals were detected with
chemiluminescence (ECL, Amersham Pharmacia, Arlington Heights, IL).
Adhesive tape hair loss test A 1 cm2 piece of adhesive tape was
gently pressed on the nape of the neck of approximately 23-d-old mice
Figure 1. Genetic and expression analysis of DSG3±/± and K14-
DSG1FLAG TG mice. (A) The TG placed mouse Dsg1 cDNA under
the control of keratin 14 promoter. Nucleotides encoding the FLAG
peptide sequence were added to the 3¢ terminus of the coding sequence.
The TG was excised from the pGEM 3Z vector with restriction
enzymes of XhoI and HidIII. (B) Genotype analysis by PCR with three
sets of primers: DSG3 exon 1 (200 bp product), neomycin DNA
(300 bp product), and TG (288 bp product). (C) Expression of the TG
was detected by Western blotting for the FLAG-tagged mouse Dsg1
from extracts of skin from transgenic 20-d-old mouse. Skin extract from
an involucrin-DSG3FLAG transgenic mouse was used as a positive
control. Extracts from tongue of TG mice did not show FLAG staining.
Figure 2. Weight gain of DSG3+/±TG±, DSG3±/±TG±, and
DSG3±/±TG+ mice. The TG did not protect DSG3±/± mice from
poor weight gain.
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(in the ®rst telogen phase of hair growth), and then gently pulled off in
the direction of hair growth (i.e., toward the tail). Tape was
photographed and weighed (before and after stripping).
RESULTS
Genetic and expression analysis of DSG3±/± and K14-
DSG1FLAG transgenic mice To determine whether Dsg1
expression could compensate for the genetic loss of Dsg3 in mice,
we ®rst generated transgenic mouse expressing mouse Dsg1 in the
deep epidermis, where Dsg3 is normally expressed, by using mouse
Dsg1 cDNA under the control of the keratin 14 promoter. In
addition, nucleotides encoding the FLAG peptide sequence were
added to the 3¢ terminus of the coding sequence for mouse Dsg1 to
create an epitope for detecting expression (Fig 1A).
Figure 3. Immuno¯uorescence for TG
expression in the telogen hair club. DSG3±/±
TG+ mice showed positive staining of Dsg1 and
FLAG at cell±cell contacts in the telogen hair club
but Dsg3 is absent. DSG3±/±TG± mouse skin
showed no staining of Dsg1, Dsg3, or FLAG, and
DSG3+/±TG+ mice showed intense staining of
both Dsg1 and Dsg3 in the telogen hair club. Bar:
50 mm.
Figure 4. K14-DSG1 reversed the phenotype of telogen hair loss in DSG3±/± mice. The DSG3±/±TG± mouse lost hair from head to tail
during the ®rst (A) and second (B) telogen cycles, whereas the DSG3±/±TG+ littermate retains its hair.
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Analysis by PCR with primers in the rabbit b-globin intron and
5¢ region of mouse Dsg1 cDNA identi®ed a band of 288 bp in
TG+ mice (Fig 1B). This genotyping was con®rmed by Southern
blotting (data not shown). Two independent transgenic mouse lines
were obtained, and both showed grossly normal phenotypes.
These transgenic mice were then bred to the DSG3±/± line to
generate DSG3±/±TG+ mice by ®rst generating DSG3+/±TG+/±
mice that were interbred to generate DSG3±/±TG+ mice. Analysis
by PCR with three sets of primers, in DSG3 exon 1, neomycin
DNA, and the b-globin intron sequence in the TG, were used to
identify DSG3+/+, DSG3+/±, and DSG3±/± mice with and
without the TG (Fig 1B).
Expression of the TG was detected by Western blotting for the
FLAG-tagged mouse Dsg1 of extracted skin from transgenic 20-d-
old mice (Fig 1C). Skin extracts from involucrin-DSG3FLAG
transgenic mouse (Wu et al, 2000) were used as positive controls.
Immuno¯uorescence staining for the FLAG epitope tag showed
expression of the TG in the deep epidermis (data not shown).
TG expression did not reverse wasting of DSG3 knockout
mice DSG3±/± mice show poor weight gain, presumably due to
blisters in the mucous membranes secondary to trauma from
suckling. To determine whether the presence of the TG in
DSG3±/± mice could reverse poor weight gain, we compared the
weights of DSG3±/±TG± and DSG3±/±TG+ mice from 6 d to
20 d (Fig 2). This analysis indicated that the TG did not reverse
poor weight gain in DSG3±/± mice. To con®rm that the TG was
actually expressed in oral mucous membranes, as it was in
epidermis, we performed immuno¯uorescence (not shown) and
Western blotting of tongue extracts with anti-FLAG antibodies
(Fig 1C). Surprisingly, the TG product was not detected,
suggesting it was either expressed very weakly compared to skin
or rapidly degraded at least in tongue, and indicating that
compensation in oral mucous membrane could not be evaluated
using these mice.
TG expression reversed loss of telogen hair in DSG3
knockout mouse As compensation in mucous membrane
could not be evaluated, we analyzed the other prominent
phenotype of DSG3±/± mice, telogen hair loss. In normal mice,
Dsg3 is the only Dsg in the telogen hair club, which is normally
anchored in the outer root sheath of the hair follicle until the next
anagen hair grows in. In DSG3±/± mice, the telogen club is not
anchored properly and is prematurely shed due to loss of cell
adhesion between the keratinocytes in the club and the outer root
sheath.
First we determined if the transgenic Dsg1 was expressed in the
telogen hair club. Figure 3 con®rms that transgenic mice, whether
they express Dsg3 or are Dsg3 knockouts, express Dsg1 on the cell
surface of keratinocytes in the telogen hair club. Furthermore the
FLAG epitope is detected in the telogen hair club, con®rming that
the TG is expressed. These data are consistent with the ®nding of
K14 expression in the keratinocytes of the hair club (Bowden et al,
1998).
Because Dsg1 replaced Dsg3 in the telogen hair club of
transgenic Dsg3 knockout mice, we could determine if it
compensated for telogen hair loss by comparing hair loss in
DSG3±/±TG± and DSG3±/±TG+ mice. As previously described
(Koch et al, 1998), DSG3±/±TG± mice lose hair from head to tail
in the ®rst wave of synchronized telogen starting about age 25±28 d
(Fig 4A). With the second anagen wave, the hair grows back from
head to tail, but then is lost again in the second telogen wave
(Fig 4B). In later cycles the hair is less synchronized so that
DSG3±/± mice show patchy hair loss (Koch et al, 1998). Strikingly,
DSG3±/±TG+ mice show little, if any, hair loss in the ®rst and
second telogen waves (Fig 4A, B). Eight DSG3±/±TG+ mice
were analyzed and seven mice showed reduced hair loss and
delayed starting of hair loss compared to DSG3±/±TG± mice. One
DSG3±/±TG+ mouse showed extensive hair loss like DSG3±/±
TG± mice.
To try to semiquantitate this telogen hair loss, we used an
adhesive tape hair pull assay (Koch et al, 1998; and see Materials and
Methods). Adhesive tape was applied and removed from the nape of
the neck of 21±23-d-old mice, just at the onset of telogen. Gross
inspection of the tape indicates that DSG3±/±TG± mice lose much
more hair than DSG3±/±TG+ mice. DSG3±/±TG+ mice do show
Figure 5. Adhesive tape hair pull test. On days 21±23, just before
clinical hair loss in DSG3±/± mice, 1 cm2 adhesive tape was applied to
and gently removed from the nape of the neck. The hair on the
adhesive tape was photographed (A) and weighed (B). DSG3±/±TG+
mice had much less hair loss than DSG3±/±TG± mice but still more
than DSG3+/±TG+ mice.
Figure 6. Histology of telogen hair in
DSG3±/±TG+ compared to DSG3±/±TG±
mice. Hematoxylin and eosin staining of the
telogen hair follicle of DSG3±/±TG± mice
showed acantholysis in the club; however, we
could not detect acantholysis in the telogen hair
club of DSG3±/±TG+ mice. Scale bar: 50 mm.
30 HANAKAWA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
more hair loss than mice that express Dsg3, however (Fig 5A).
Quantitation of these results by weights of hair pulls is shown in
Fig 5(B).
Finally, we con®rmed by histology that, whereas DSG3±/±TG±
mice showed acantholysis (loss of cell adhesion) in the telogen hair
club (N = 6), DSG3±/±TG+ mice did not (N = 7) (Fig 6).
Interestingly, after the second telogen hair cycle DSG3±/±TG+
mice showed increasing hair loss correlating with decreased TG
expression as determined by Western blotting. By this time the hair
loss was dif®cult to evaluate comparatively between DSG3±/±TG±
and DSG3±/±TG+ mice, however, because the hair cycle was no
longer synchronized and the hair loss was sporadic and patchy.
DISCUSSION
The idea that one Dsg isoform can substitute for another in
adhesion is suggested by studies of the autoimmune blistering
diseases pemphigus vulgaris and foliaceus. In these diseases antibody
inactivation of Dsg1 or Dsg3 does not result in a blister if the other
Dsg is coexpressed in the same area (Mahoney et al, 1999; Wu et al,
2000). This correlation is consistent with the so-called Dsg
compensation hypothesis. More direct proof comes from studies
in transgenic mice in which forced expression of Dsg3 in the
super®cial epidermis prevents anti-Dsg1 pemphigus foliaceus
antibodies from causing a super®cial epidermal blister (Wu et al,
2000). The latter study suggested that Dsg3 could compensate for
adhesion from antibody-induced loss of function of Dsg1. The
exact pathway in which antibodies might inactivate Dsg is not
known, however; therefore it is possible that expression of Dsg3
could somehow interfere with the pathway of inactivation rather
than directly compensate for function.
We therefore sought direct genetic proof of the Dsg compen-
sation hypothesis. In this study we show that forced expression of
Dsg1 in the telogen hair club prevents loss of cell adhesion due to
absence of Dsg3 in this area. This result demonstrated that Dsg1 can
compensate, at least partially, for the adhesive function of Dsg3 in
the desmosome. The compensation, however, was not perfect in
that there was some increased hair loss in some DSG3±/±TG+
mice compared to normal mice even in the ®rst two telogen cycles.
This is not unexpected and may be due to the fact that the
expression levels of the TG Dsg1 are not regulated properly because
the K14 promoter will not mimic perfectly the Dsg3 promoter.
Another possibility is that although Dsg1 can compensate for Dsg3
under normal conditions, in some areas one Dsg may be superior to
another if there is mechanical stress. Until we know much more
about the biophysical mechanisms of adhesion in the desmosome,
however, the clari®cation of this possibility will remain elusive.
In this study, we could not show Dsg1 compensation for absence
of Dsg3 in the mucous membranes. Although K14 should be
expressed in the basal layer of the mucous membranes, in our K14-
DSG1 TG, in two founders, DSG1 was not expressed strongly, as
determined by immuno¯uorescence and immunoblotting. We
have no explanation for these ®ndings, although they could be due
to either inactivation of the TG, integration effects, and/or
degradation of the product. Level of expression correlated grossly
with the ability to compensate for loss of Dsg3 function, however.
If one Dsg isoform can compensate for another in adhesion,
could there be a function other than adhesion that requires the
various isoforms? A recent study indicates that the distribution of
Dsg isoforms affects the epidermal barrier (Elias et al, 2001). Normal
mice only express Dsg3 in the deep epidermis, and not in the more
super®cial epidermis, whereas they express Dsg3 throughout the
mucous membranes. Transgenic mice with mouse Dsg3 controlled
by the involucrin promoter express the Dsg3 isoform in the same
distribution in epidermis as in mucous membrane. These mice
show a severe barrier defect with markedly increased transepider-
mal water loss, probably due to premature degradation of
corneodesmosomes in epidermal stratum corneum.
With these ®ndings in mind, it is likely that Dsg isoforms have
more than one function. Adhesion is a major function, however,
and its importance is underscored by the loss of this function
causing the life-threatening blistering diseases pemphigus vulgaris
and foliaceus. This study con®rms that Dsg compensation in
adhesion can occur, and validates the Dsg compensation hypothesis
as an explanation for blister localization in these diseases.
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